These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17009092)

  • 21. Identification of novel VP35 inhibitors: Virtual screening driven new scaffolds.
    Ren JX; Zhang RT; Zhang H; Cao XS; Liu LK; Xie Y
    Biomed Pharmacother; 2016 Dec; 84():199-207. PubMed ID: 27657828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters.
    Wolber G; Langer T
    J Chem Inf Model; 2005; 45(1):160-9. PubMed ID: 15667141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer.
    Singh PK; Silakari O
    J Mol Model; 2018 Oct; 24(11):318. PubMed ID: 30343450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
    Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
    J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2013 Apr; 8(4):411-26. PubMed ID: 23373617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore.
    Siani MA; Skillman AG; Carreras CW; Ashley G; Kuntz ID; Santi DV
    J Mol Graph Model; 2000; 18(4-5):497-511, 539-40. PubMed ID: 11143565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virtual screening of cathepsin k inhibitors using docking and pharmacophore models.
    Ravikumar M; Pavan S; Bairy S; Pramod AB; Sumakanth M; Kishore M; Sumithra T
    Chem Biol Drug Des; 2008 Jul; 72(1):79-90. PubMed ID: 18498326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo design based pharmacophore query generation and virtual screening for the discovery of Hsp-47 inhibitors.
    Katarkar A; Haldar PK; Chaudhuri K
    Biochem Biophys Res Commun; 2015 Jan; 456(3):707-13. PubMed ID: 25522881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Library design and virtual screening using multiple 4-point pharmacophore fingerprints.
    Mason JS; Cheney DL
    Pac Symp Biocomput; 2000; ():576-87. PubMed ID: 10902205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pseudo-ligand approach to virtual screening.
    Schüller A; Fechner U; Renner S; Franke L; Weber L; Schneider G
    Comb Chem High Throughput Screen; 2006 Jun; 9(5):359-64. PubMed ID: 16787149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All in One: Cavity Detection, Druggability Estimate, Cavity-Based Pharmacophore Perception, and Virtual Screening.
    Tran-Nguyen VK; Da Silva F; Bret G; Rognan D
    J Chem Inf Model; 2019 Jan; 59(1):573-585. PubMed ID: 30563339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
    Forli S; Huey R; Pique ME; Sanner MF; Goodsell DS; Olson AJ
    Nat Protoc; 2016 May; 11(5):905-19. PubMed ID: 27077332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
    Rollinger JM; Haupt S; Stuppner H; Langer T
    J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.
    Gogoi D; Chaliha AK; Sarma D; Kakoti BB; Buragohain AK
    Biomed Pharmacother; 2017 Jan; 85():646-657. PubMed ID: 27903422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast and efficient in silico 3D screening: toward maximum computational efficiency of pharmacophore-based and shape-based approaches.
    Kirchmair J; Ristic S; Eder K; Markt P; Wolber G; Laggner C; Langer T
    J Chem Inf Model; 2007; 47(6):2182-96. PubMed ID: 17929799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacophore modeling and parallel screening for PPAR ligands.
    Markt P; Schuster D; Kirchmair J; Laggner C; Langer T
    J Comput Aided Mol Des; 2007; 21(10-11):575-90. PubMed ID: 17960326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge-based virtual screening: application to the MDM4/p53 protein-protein interaction.
    Jacoby E; Boettcher A; Mayr LM; Brown N; Jenkins JL; Kallen J; Engeloch C; Schopfer U; Furet P; Masuya K; Lisztwan J
    Methods Mol Biol; 2009; 575():173-94. PubMed ID: 19727615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screening.
    von Korff M; Freyss J; Sander T; Boss C; Ciana CL
    J Chem Inf Model; 2012 Feb; 52(2):380-90. PubMed ID: 22251316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.